Amplitude Surgical (AMPLI) Q3 24/25 earnings summary

Executive summary

• Consolidated sales for the first 9 months of FY 2024-25 reached €83.8 million, up 6.4% at constant exchange rates compared to the same period last year.

• Q3 FY 2024-25 sales increased 6.6% at constant exchange rates, maintaining the growth trajectory.

Financial highlights

• 9-month sales rose 5.3% at current exchange rates and 6.4% at constant exchange rates year-over-year.

• Q3 sales totaled €32.3 million, up 5.7% at current exchange rates and 6.6% at constant exchange rates year-over-year.

Segment performance

• France contributed about 72% of group sales, with 9-month sales up 4.7%.

• International business grew 11.1% at constant exchange rates over 9 months; international subsidiaries up 12.6% and distributors up 6.6% at constant exchange rates.

• Q3 international subsidiaries grew 12.4% and distributors 12.3% at constant exchange rates.

• Growth in Belgium, Australia, Brazil, and South Africa; declines in Germany and Switzerland.